JPS5151526A - Tekunechiumuu99m hyoshikitsukihoshasenshindanzaooyobi sonoseizoho - Google Patents

Tekunechiumuu99m hyoshikitsukihoshasenshindanzaooyobi sonoseizoho

Info

Publication number
JPS5151526A
JPS5151526A JP50103546A JP10354675A JPS5151526A JP S5151526 A JPS5151526 A JP S5151526A JP 50103546 A JP50103546 A JP 50103546A JP 10354675 A JP10354675 A JP 10354675A JP S5151526 A JPS5151526 A JP S5151526A
Authority
JP
Japan
Prior art keywords
solution
carrier
tartrate
albumin
aug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50103546A
Other languages
English (en)
Japanese (ja)
Inventor
Jozefu Morinsukii Bikutaa
Aasaa Uirucheusuki Jozefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Union Carbide Corp
Original Assignee
Union Carbide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Carbide Corp filed Critical Union Carbide Corp
Publication of JPS5151526A publication Critical patent/JPS5151526A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50103546A 1974-08-29 1975-08-28 Tekunechiumuu99m hyoshikitsukihoshasenshindanzaooyobi sonoseizoho Pending JPS5151526A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/501,704 US3987157A (en) 1974-08-29 1974-08-29 Technetium 99-m labeled radio-diagnostic agents employing stannous tartrate and method of preparation

Publications (1)

Publication Number Publication Date
JPS5151526A true JPS5151526A (en) 1976-05-07

Family

ID=23994693

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50103546A Pending JPS5151526A (en) 1974-08-29 1975-08-28 Tekunechiumuu99m hyoshikitsukihoshasenshindanzaooyobi sonoseizoho
JP4181778A Pending JPS542343A (en) 1974-08-29 1978-04-11 Radioactive diagnostic agent labelled with tecnetium 99m and production thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP4181778A Pending JPS542343A (en) 1974-08-29 1978-04-11 Radioactive diagnostic agent labelled with tecnetium 99m and production thereof

Country Status (7)

Country Link
US (1) US3987157A (enExample)
JP (2) JPS5151526A (enExample)
CA (1) CA1058518A (enExample)
DE (1) DE2538388C3 (enExample)
FR (2) FR2282909A1 (enExample)
GB (2) GB1508899A (enExample)
NL (1) NL7510194A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271102A (ja) * 1991-04-09 1993-10-19 Merck Frosst Canada Inc 放射性薬剤の制菌剤

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054645A (en) * 1976-08-24 1977-10-18 Minnesota Mining And Manufacturing Company Radiodiagnostic complexes employing fluorine-containing tin reducing agents
US4233284A (en) * 1978-03-31 1980-11-11 The Procter & Gamble Company Stabilized radiographic scanning agents
GB2042887B (en) * 1979-02-22 1983-10-12 New England Nuclear Corp Albumin microaggregates for radioactive scanning of reticuloendothelial systems
EP0045817B1 (en) * 1980-08-11 1987-05-13 E.I. Du Pont De Nemours And Company Denatured albumin complexes for radioscintigraphic imaging and evaluation of reticuloendothelial systems
JPS5750928A (en) * 1980-09-13 1982-03-25 Nippon Mejifuijitsukusu Kk Diagnostic agent for scanning bone
US4406876A (en) * 1980-10-14 1983-09-27 Research Foundation Of The State Univ. Of New York Sulfur free small-particle production of technetium sulfur colloid
US4455291A (en) * 1982-01-22 1984-06-19 New England Nuclear Corporation Accelerators for forming cationic technetium complexes useful as radiodiagnostic agents
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
JPS58163606U (ja) * 1982-04-27 1983-10-31 「と」　協意 ボイラによる動力発生装置
US4374821A (en) * 1982-06-28 1983-02-22 E. R. Squibb & Sons, Inc. Myocardial imaging agent and method
US4673562A (en) * 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4582700A (en) * 1983-09-01 1986-04-15 Mallinckrodt, Inc. Products and processes
US4610391A (en) * 1984-12-18 1986-09-09 Union Carbide Corporation Process for wave soldering
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
US5089249A (en) * 1988-06-10 1992-02-18 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
US5202109A (en) * 1988-06-10 1993-04-13 Neorx Corporation Conjugates for bone imaging and bone cancer therapy
EP0498333B1 (de) * 1991-02-05 1997-01-15 Cis Bio International Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz
US6730286B2 (en) 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786566A (fr) * 1971-07-20 1973-01-22 Squibb & Sons Inc Agregats a base de tc-99m et d'albumine
US3863004A (en) * 1972-03-20 1975-01-28 Mallinckrodt Chemical Works Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation
US3735001A (en) * 1972-05-24 1973-05-22 Atomic Energy Commission Technetium bone scanning medium
FR2187314B1 (enExample) * 1972-06-06 1975-06-20 Commissariat Energie Atomique
US3852414A (en) * 1972-09-13 1974-12-03 New England Nuclear Corp Bone seeking technetium 99m stannous phosphate complex
CA1027135A (en) * 1973-06-11 1978-02-28 Research Corporation Bone-seeking technetium-99m complex

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271102A (ja) * 1991-04-09 1993-10-19 Merck Frosst Canada Inc 放射性薬剤の制菌剤

Also Published As

Publication number Publication date
DE2538388A1 (de) 1976-03-11
DE2538388C3 (de) 1979-06-28
GB1508899A (en) 1978-04-26
DE2538388B2 (de) 1978-10-26
FR2282909B1 (enExample) 1979-05-25
US3987157A (en) 1976-10-19
CA1058518A (en) 1979-07-17
NL7510194A (nl) 1976-03-02
JPS542343A (en) 1979-01-09
FR2366021A1 (fr) 1978-04-28
GB1508900A (en) 1978-04-26
FR2282909A1 (fr) 1976-03-26

Similar Documents

Publication Publication Date Title
JPS5151526A (en) Tekunechiumuu99m hyoshikitsukihoshasenshindanzaooyobi sonoseizoho
AU8726582A (en) Intravenously injectable immune serum globulin
DE2962569D1 (en) Immune serum globulin preparations and method to produce them
GB1465347A (en) Composition
MY102852A (en) O/w type emulsion composition.
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
KR920007639A (ko) 방사능의약품 조성물의 제조방법
GB1469862A (en) Therapeutic compositions containing etherified monosaccharide derivatives and method of using the same
SE8300320L (sv) Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
ZA832044B (en) Imidazolyphenyl-tetrahydropyridazines,processes for their preparation and pharmaceutical preparation containing them
FR2088139B1 (enExample)
KR840006492A (ko) 플라티늄-디아민 착화물의 제조 방법
IE41923L (en) Suspension of xanthan gum
DE3562220D1 (en) Water soluble compositions for preparing analytical solutions
JPS5486635A (en) First liquid of cold-wave lotion
GB1465320A (en) Process for the preparation of perfume compositions and perfumed articles
IL71886A0 (en) Liquid prolonged release pharmaceutical compositions containing ionic constituents
Hirschfeld et al. Autoradiographs of human sera tagged with radioactive thyroxine and investigated in immunoelectrophoresis
FR2187307B1 (enExample)
GB1388863A (en) Hydroxy- and alkoxy-acetamido-triiodobenzoic acids
GB1346528A (en) Heterocyclic-substituted nebularin derivatives
DE3360838D1 (en) Composition for coating objects
GB1469121A (en) Technetium-labelled complexes production and use thereof
GB1265930A (enExample)
SE8105340L (sv) Nya 4-karbamoyloxioxazafosforiner samt forfarande for framstellning derav